- Report
- October 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,603GBP
- Report
- November 2023
- 76 Pages
France
From €3358EUR$3,500USD£2,892GBP
- Report
- October 2023
- 90 Pages
Malaysia
From €3358EUR$3,500USD£2,892GBP
- Report
- October 2023
- 73 Pages
India
From €3358EUR$3,500USD£2,892GBP
- Report
- August 2023
- 74 Pages
Egypt
From €3358EUR$3,500USD£2,892GBP
- Report
- February 2023
- 115 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- November 2023
- 80 Pages
Germany
From €3358EUR$3,500USD£2,892GBP
- Report
- August 2022
- 120 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- October 2023
- 146 Pages
Global
From €3385EUR$3,528USD£2,915GBP
€3982EUR$4,150USD£3,430GBP
- Report
- February 2023
Global
From €816EUR$850USD£702GBP
- Report
- March 2022
Global
From €4654EUR$4,850USD£4,008GBP
- Report
- July 2020
Japan, United States, ... Japan, United States, Europe, Global
From €720EUR$750USD£620GBP
From €720EUR$750USD£620GBP
The Microalbumin Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of albumin in urine. Albumin is a protein produced by the liver and is an important indicator of kidney health. The test is used to detect early signs of kidney damage, which can be caused by a variety of conditions, such as diabetes, hypertension, and lupus. The test is typically performed in a laboratory setting, and results are usually available within 24 hours.
The Microalbumin Test market is a growing segment of the IVD industry, with a wide range of products available from various manufacturers. These products include test kits, reagents, and instruments. Many of these products are designed to be used in both clinical and home settings, allowing for greater convenience and cost savings.
Some of the major companies in the Microalbumin Test market include Abbott, Siemens, Roche, and Beckman Coulter. Show Less Read more
